cyclosporine has been researched along with Parkinson Disease, Secondary in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avčin, S; Jazbec, J; Kojović, M; Miklavčič, P; Todorova, B; Trošt, M; Vipotnik Vesnaver, T | 1 |
Chiba, S; Freed, CR; Lee, YM; Zhou, W | 1 |
Caviedes, P; Couve, E; LeDoux, S; Paris, I; Perez-Pastene, C; Segura-Aguilar, J | 1 |
Earl, CD; Kupsch, A; Oertel, WH; Sautter, J | 1 |
Chen, XL; Gupta, M; Roisen, FJ | 1 |
Honig, LS; Wasserstein, PH | 1 |
Earl, CD; Kupsch, AR; Oertel, WH; Sauer, H; Schwarz, SC | 1 |
Kabuto, H; Makino, H; Matsuura, K; Ogawa, N | 1 |
Honey, CR; Shen, H | 1 |
1 review(s) available for cyclosporine and Parkinson Disease, Secondary
Article | Year |
---|---|
[Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
Topics: Animals; Brain Tissue Transplantation; Cryopreservation; Cyclosporine; Disease Models, Animal; Dopamine; Fetal Tissue Transplantation; Graft Rejection; Humans; Immunosuppressive Agents; Mesencephalon; Parkinson Disease; Parkinson Disease, Secondary; Rats | 1995 |
8 other study(ies) available for cyclosporine and Parkinson Disease, Secondary
Article | Year |
---|---|
Cyclosporine A induced dystonia-parkinsonism.
Topics: Adolescent; Bone Marrow Transplantation; Brain; Cyclosporine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Parkinson Disease, Secondary | 2017 |
Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats.
Topics: Animals; Bone Morphogenetic Protein 4; Carrier Proteins; Cell Differentiation; Cell Line; Cell Survival; Cyclosporine; Dopamine; Embryonic Stem Cells; Gene Knock-In Techniques; Humans; Immunosuppressive Agents; Male; Neurons; Parkinson Disease, Secondary; Rats; SOXB1 Transcription Factors; Stereotyped Behavior; Stromal Cells | 2008 |
Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death.
Topics: Animals; Apoptosis; Autophagy; Caspases; Cell Line; Copper; Cyclosporine; Dicumarol; DNA Fragmentation; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Occupational Exposure; Parkinson Disease, Secondary; Rats; Vacuoles | 2009 |
The effect of prior in vitro exposure of donor cells to trophic factors in neurotransplantation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Differentiation; Cricetinae; Cyclosporine; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neurons; Parkinson Disease, Secondary; PC12 Cells; Rats; Tyrosine 3-Monooxygenase | 1996 |
Parkinsonism during cyclosporine treatment.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Parkinson Disease, Secondary | 1996 |
Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Cyclosporine; Female; Fetal Tissue Transplantation; Graft Survival; Immunosuppressive Agents; Mesencephalon; Mice; Mice, Inbred C57BL; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Sympatholytics; Transplantation, Heterologous; Tyrosine 3-Monooxygenase | 1997 |
Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice.
Topics: Animals; Corpus Striatum; Cyclosporine; Disease Models, Animal; Dopamine; Glucocorticoids; Hydrocortisone; Immunosuppressive Agents; Male; Mice; Mice, Inbred ICR; Oxidopamine; Parkinson Disease, Secondary; Sympatholytics | 1997 |
Immunosuppression for neural xenografts: a comparison of cyclosporin and anti-CD25 monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Disease Models, Animal; Fetal Tissue Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mesencephalon; Mice; Parkinson Disease, Secondary; Rats; Rats, Wistar; Receptors, Interleukin-2; Transplantation, Heterologous; Treatment Outcome | 1999 |